Category Archives: Fifth Avenue Concierge Medicine
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.
J Neurol Neurosurg Psychiatry. 2012 May;83(5):565-71. doi: 10.1136/jnnp-2011-301876. Epub 2012 Feb 22. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis. Soilu-Hänninen M, Aivo J, Lindström … Continue reading
A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment.
Mult Scler Int. 2012;2012:802796. doi: 10.1155/2012/802796. Epub 2012 Aug 5. A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment. Aivo J, Lindsröm BM, Soilu-Hänninen M. Source Department of … Continue reading
Vitamin D status predicts new brain magnetic reso… [Ann Neurol. 2012] – PubMed – NCBI
Ann Neurol. 2012 Aug;72(2):234-40. doi: 10.1002/ana.23591. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, Gourraud PA, Brenneman D, Owen MC, Qualley P, Bucci … Continue reading
The influence of nutritional factors on the prognosis of multiple sclerosis : Article : Nature Reviews Neurology
Nature Reviews Neurology 8, 678-689 (December 2012) | doi:10.1038/nrneurol.2012.194 Subject Categories: Neuroimmunology and neuroinflammation | White matter disease The influence of nutritional factors on the prognosis of multiple sclerosis Gloria von Geldern & Ellen M. Mowry About the … Continue reading
Can MRI screen for CSF biomarkers in neurodegenerative disease?
Imaging advances are always potentially interesting but the immediate risk might be more dementia diagnoses delivered without much regard to functional context, and without proper support and follow-up. Can MRI screen for CSF biomarkers in neurodegenerative disease? Corey T. McMillan, … Continue reading